The Merck Manual of Health and Aging
Posted on: Sunday, 6 March 2005, 03:00 CST
The Merck Manual of Health and Aging
Practically everything you need to know about how to optimize the process of aging, improve health, and prevent disease can be found in this comprehensive guide from Merck & Co., from how to improve nutrition, to the many causes and treatments for dizziness, to the ins and outs of Medicare, Medicaid, and private insurance.
This is more than a reference book, however. The entries are clear and easy to follow and are interspersed with inspiring essays by active older Americans, including a lady physician who worked as a pediatrician for 70 years, and a professional aviator who is still actively flying at age ninety-eight. Four informative sections cover the Fundamentals of Aging, Caring for Self and Others, Medical Conditions, and Social, Legal, and Ethical Issues.
In addition to easy-to-understand descriptions of symptoms, causes, and treatments for more than 40 common aging-related disorders, this new manual offers useful information on many commonly prescribed pharmaceuticals and their possible side effects.
Published by Merck Research Laboratories, 2004 by Merck & Co., Inc.
Copyright Benjamin Franklin Literary and Medical Society Mar/Apr 2005
Source: Saturday Evening Post, The
Related Articles
- Merck & Co., Inc Receives Complete Response Letter From the Food and Drug Administration for Use of GARDASIL(R) in Women Ages 27 Through 45
- CDC Recommends ZOSTAVAX(R), Merck's Shingles Vaccine, for All Appropriate Adults Aged 60 and Older
- New Data Presented on GARDASIL(R), Merck's Cervical Cancer Vaccine, in Women Through Age 45
- CDC Advisory Panel Votes to Recommend Merck's Shingles Vaccine, ZOSTAVAX(R), for Vaccination of Adults Age 60 and Over
- FDA Approves ZOSTAVAX(R), Merck's New Vaccine for Prevention of Shingles in Adults Age 60 and Older
- FDA Advisory Committee Agrees That Clinical Data Support the Efficacy and Safety of Zostavax(TM), Merck's Investigational Vaccine for Shingles, in Adults Aged 60 and Older
- FDA Approves Expanded Age Indication for VAQTA(R) (Hepatitis A Vaccine, Inactivated), Merck's Hepatitis A Vaccine, to Children As Young As 12 Months of Age
- New Twist to the Board
- New Merck Guide Details Aging Process
 |
 |
User Comments (0)
RSS Feeds